CLAIM #33837 · Johnson & Johnson (JNJ) · 2024Q1 earnings call · Apr 16, 2024 · due Dec 31, 2024
“As you know, we are expecting to deliver the fourth consecutive year of global share gains driven primarily by tremendous performances of our IOL business in Asia Pac and in EMEA.”
Joaquin Duato · CEO
PENDING
graded after results covering Dec 31, 2024 are reported
Verify independently
SEC filings for JNJ ↗ · Claim quote is verbatim from the 2024Q1 earnings call.